Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation.
about
Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma.Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.Factors associated with relapse in adult patients discharged from the emergency department following acute asthma: a systematic review.Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada.The nature and influence of pharmaceutical industry involvement in asthma trials.
P2860
Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Long-acting beta(2)-agonist an ...... comes and economic evaluation.
@en
type
label
Long-acting beta(2)-agonist an ...... comes and economic evaluation.
@en
prefLabel
Long-acting beta(2)-agonist an ...... comes and economic evaluation.
@en
P2860
P1476
Long-acting beta(2)-agonist an ...... tcomes and economic evaluation
@en
P2093
Canadian Agency for Drugs and Technologies in Health (CADTH)
P2860
P577
2010-09-01T00:00:00Z